Avadel Pharmaceuticals (AVDL) announced the appointment of Susan Rodriguez as COO. In this newly created role, Rodriguez will lead all aspects of the company’s commercial strategy, structure, organization, and related operations, including supply chain.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVDL:
- Avadel Pharmaceuticals Sees Strong Q1 Growth, Raises Guidance
- Avadel Pharmaceuticals’ Earnings Call Highlights Growth and Optimism
- Avadel Pharmaceuticals reports Q1 EPS (5c), consensus (7c)
- Avadel Pharmaceuticals sees FY25 revenue $255M-$265M, consensus $249.16M
- Avadel Pharmaceuticals sees Q2 revenue $60M-$63M, consensus $58.21M